LYKA LABS
Back to Cashflow Statement
|
LYKA LABS Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹1.90 Cr | ₹1.77 Cr | ₹8.95 Cr | ₹79 Cr | ₹8.81 Cr |
What is the latest Cash Flow from Operating Activities ratio of LYKA LABS ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹1.90 Cr |
| Mar2024 | ₹1.77 Cr |
| Mar2023 | ₹8.95 Cr |
| Mar2022 | ₹79 Cr |
| Mar2021 | ₹8.81 Cr |
How is Cash Flow from Operating Activities of LYKA LABS Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1.90 Cr | 7.11 | |
| Mar2024 | ₹1.77 Cr | -80.20 | |
| Mar2023 | ₹8.95 Cr | -88.70 | |
| Mar2022 | ₹79 Cr | 799.30 | |
| Mar2021 | ₹8.81 Cr | - | |
Compare Cash Flow from Operating Activities of peers of LYKA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LYKA LABS | ₹215.4 Cr | -3.8% | -15.5% | -41.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹431,628.0 Cr | 3.5% | 5.6% | 11.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,975.0 Cr | -1.3% | 4.5% | 16.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹145,804.0 Cr | -0.7% | 6.9% | 47.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,829.0 Cr | 1.3% | 5.1% | 17.5% | Stock Analytics | |
| CIPLA | ₹106,768.0 Cr | -1.9% | -0.3% | -6% | Stock Analytics | |
LYKA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LYKA LABS | -3.8% |
-15.5% |
-41.6% |
| SENSEX | -4.1% |
-5.8% |
5.8% |
You may also like the below Video Courses